" /> Personalized Peptide Cancer Vaccine mBTCvax - CISMeF





Preferred Label : Personalized Peptide Cancer Vaccine mBTCvax;

NCIt synonyms : mBTCvax;

NCIt definition : A peptide-based, personalized cancer therapeutic vaccine consisting of patient-specific mutated tumor peptides, which are immunogenic and unique to the patient's tumor, combined with the immunostimulant polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose (poly-ICLC), with potential immunomodulating and antineoplastic activities. Upon administration, personalized peptide cancer vaccine mBTCvax stimulates the host immune system to mount a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis. The adjuvant poly-ICLC is a ligand for toll-like receptor-3 (TLR3) and induces the release of cytokines which may help to boost the immune response against the selected neoantigens.;

Details


You can consult :


Nous contacter.
13/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.